| Business Summary | | U.S.
Neurosurgical,
Inc.
(USN)
owns
and
operates
stereotactic
radiosurgery
centers,
utilizing
the
Gamma
Knife
technology.
USN
currently
owns
and
operates
two
Gamma
Knife
centers,
one
on
the
premises
of
Research
Medical
Center
(RMC)
in
Kansas
City,
MO,
and
one
on
the
premises
of
New
York
University
Medical
Center
(NYU)
in
New
York,
NY.
The
Company
intends
to
continue
to
explore
opportunities
to
open
additional
Gamma
Knife
Centers.
USN's
business
strategy
is
to
provide
a
mechanism
whereby
hospitals,
physicians,
and
patients
can
have
access
to
Gamma
Knife
treatment
capability,
a
high
capital
cost
item.
USN
provides
the
Gamma
Knife
to
medical
facilities
on
a
"cost
per
treatment"
basis.
USN
owns
the
Gamma
Knife
units,
and
is
reimbursed
by
the
facility
where
it
is
housed,
based
on
utilization. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | U.S.
Neurosurgical
owns
and
operates
stereotactic
radiosurgery
centers,
utilizing
the
Gamma
Knife
technology.
For
the
six
months
ended
6/30/01,
revenues
decreased
3%
to
$1.2
million.
Net
loss
increased
from
$9
thousand
to
$126
thousand.
Revenues
reflect
the
negative
impact
of
the
implementation
of
the
Ambulatory
Product
Classifications
Medicare
outpatient
payment
system.
Higher
loss
reflects
an
increase
in
patient
expenses,
salaries
and
insurance
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1999 Pay | |
| Alan Gold, 55 Chairman,
Pres | $191K | Howard Grunfeld, 39 CFO,
VP-Fin., Treasurer | -- | Susan Greenwald, 54 VP
of Marketing Communications, Sec. | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|